ArticleFrontiers in oncology2023

Development and validation of nomogram models to predict radiotherapy or chemotherapy benefit in stage III/IV gastric adenocarcinoma with surgery.

Xiangqing Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.